Occurrence of gouty tophi following acitretin therapy.

Clin Exp Dermatol

Department of Dermatology and Venereology, University Hospital St Pierre, 129, Boulevard de Waterloo, B 1000, Brussel, Belgium.

Published: November 1998

Acitretin (Ro 10-1670 or Neotigason), a free acid and the main metabolite of etretinate (Ro 10-9359 or Tigason), is the most recent of the retinoids used orally in the treatment of psoriasis and numerous other dermatoses exhibiting disorders of keratinization. In the majority of cases, its side-effects are similar to those of hypervitaminosis A.

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2230.1998.00362.xDOI Listing

Publication Analysis

Top Keywords

occurrence gouty
4
gouty tophi
4
tophi acitretin
4
acitretin therapy
4
therapy acitretin
4
acitretin 10-1670
4
10-1670 neotigason
4
neotigason free
4
free acid
4
acid main
4

Similar Publications

Article Synopsis
  • - The study explores the potential of chlorquinaldol (CQ), an antimicrobial agent, as a specific inhibitor of the NLRP3 inflammasome, which is linked to various inflammatory diseases, highlighting its promise for drug repurposing.
  • - CQ effectively suppresses NLRP3 inflammasome activation in both mouse and human macrophages primarily by blocking the interaction between NLRP3 and ASC, while having minimal impact on other inflammasomes like NLRC4 and AIM2.
  • - In vivo tests showed that CQ significantly improves conditions in mouse models of LPS-induced peritonitis, DSS-induced colitis, and MSU-induced gouty arthritis, suggesting its therapeutic potential for treating NLRP3-related
View Article and Find Full Text PDF

Background: Gouty arthritis is a metabolic condition caused by disordered purine metabolism and elevated uric acid levels. This study adopts a bibliometric approach to analyze current research on pain in gouty arthritis and forecast future research trends.

Methods: Retrieve relevant research on gouty arthritis pain in the Web of Science core collection database, screen literature, and use visualization software such as CiteSpace, Vosviewers, and R package "Bibliometrix" for analysis.

View Article and Find Full Text PDF

Sex is a key variable in the regulation of human physiology and pathology. Many diseases disproportionately affect one sex: autoimmune diseases, such as systemic lupus erythematosus, are more common in women but more severe in men, whereas the incidence of other disorders such as gouty arthritis and malignant cancers is higher in men. Besides the pathophysiology, sex may also influence the efficacy of therapeutics; participants in clinical trials are still predominately men, and the side effects of drugs are more common in women than in men.

View Article and Find Full Text PDF
Article Synopsis
  • Gout is an inflammatory arthritis linked to high levels of uric acid in the blood, leading to crystal formation and inflammation.
  • The review highlights the rising prevalence of gout, its impact on public health, and various management strategies, including medications, dietary modifications, and lifestyle changes.
  • Recent research explores innovative treatments like nanoparticles and new drugs, as well as advanced diagnostics for better detection and management of gout.
View Article and Find Full Text PDF
Article Synopsis
  • Rhino-orbital-cerebral mucormycosis (ROCM) is a serious infection that often requires removal of the sinuses and eyeball to save patients, especially after the surge of cases following COVID-19 in India.
  • A study involving 15 ROCM cases evaluated the presence and types of fat necrosis found during surgical removal, discovering significant findings like acute necrotizing fat necrosis and crystalline fat necrosis.
  • Both CT scans and histopathological examinations confirmed fat necrosis as an important indicator of ROCM, with multiple patterns potentially present in a single case.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!